Tag Archives: Genesis biosciences

Biosciences firm launches three new application specific powder additives

Global biotechnology company Genesis Biosciences has announced the launch of three new Evogen probiotic and microbial powder additives, designed to enhance environmental sustainability while delivering superior cleaning performance.

The three powders, which include the Evogen GDL Powder, Evogen General Purpose Powder and Evogen Odour Neutraliser Powder, have been manufactured in accordance with recognised international standards ISO 9001 and ISO 14001, and are compliant with major ECO accreditations.

As highly concentrated, water-soluble microbial additives, the powders can be used to formulate products which quickly degrade organic compounds to support hygiene maintenance and waste management.

The ‘application-specific’ Evogen Powders have been extensively tested to demonstrate targeted performance across various applications. Each powder is designed with specific strains to ensure that the microbes don’t just exist in the formula – they actively get to work where they’re needed, delivering better results.

The Evogen GDL Powder probiotic additive breaks down grease, edible oils and other organic matter, and is primarily intended for use in food processing facilities, industrial cleaning applications and wastewater treatment.

Similarly, the multi-strain microbial Evogen General Purpose Powder is also suitable for use in drain maintenance, institutional and industrial cleaning, and municipal waste processing by accelerating the degradation of organic buildup on surfaces.

The targeted Bacillus blend in the Evogen Odour Neutraliser Powder has been engineered to eliminate odours at source by degrading malodorous compounds in agricultural settings, carpets, washrooms and waste collection areas.

Dr Emma Saunders, General Manager of Genesis Biosciences, said: “We are thrilled to announce the launch of our three new Evogen Powder additives, providing formulators with application specific probiotic and microbial solutions which enhance cleaning efficacy and greater environmental compatibility.

“We don’t take a one-size-fits-all approach; our specialist team use advanced molecular and microbiological screening techniques to identify and select Bacillus strains with highly specialised degradation capabilities and safety credentials to match the demands of each application. Every single strain in our formulations is carefully chosen for its ability to break down specific organic compounds relevant to the intended use, whether it’s oils and greases, organic waste buildup or malodorous compounds.

“This targeted approach in our new Evogen Powder additives help us continue to provide formulators and manufacturers with a sustainable alternative to harsh chemicals, supporting global efforts to reduce environmental impact while maintaining high standards of hygiene.”

Safety of microbial cleaning products highlighted in European webinar

Global biotechnology company Genesis Biosciences featured the safety, efficacy and regulatory landscape of microbial-based cleaning products in a new webinar aimed at instilling confidence in the home care, industrial and institutional cleaning sectors in Europe.

Microbial-based cleaning products contain live microorganisms, such as Bacillus bacteria, which actively break down dirt and organic matter. When added to surfaces, the microbes germinate and secrete enzymes to break down complex organic matter into simpler molecules they can digest, continuing to work even after cleaning.

Dr Emma Saunders, General Manager of Genesis Biosciences, delivered the webinar to industry professionals across the UK and Europe on 19 March in the event facilitated by Marina Pellegrino, International Product Manager for IMCD Group.

Dr Emma Saunders said: “Microbial-based cleaning products are emerging as an effective alternative to traditional chemical cleaners, representing a new era of sustainable, science-backed hygiene. These products leverage naturally occurring Bacillus strains to provide long-lasting cleaning and odour control, and aid in the prevention of biofilms, black mould, FOG (fats, oils and grease) and nuisance microbes.

“We are at the beginning of an exciting shift in cleaning technology. At Genesis Biosciences, while we’re continuing to drive innovation and researching new Bacillus strains for enhanced cleaning, we’re also actively engaging with regulatory bodies to ensure a balanced framework that fosters both innovation and safety.”

During the webinar, Emma highlighted that any microbial strain used in cleaning products must be non-pathogenic and not associated with disease in healthy humans, animals or plants as per regulations such as the EU Directive 2000/54/EC, NIH Guidelines in the US and the WHO Risk Group 1 classification.

In the European Union in particular, microbial-based cleaning products are subject to multiple regulatory controls to ensure safety and sustainability including the EU Chemical Strategy for Sustainability, the EU Directive on occupational health risks of biological agents and the EU Detergents Regulation.

The European Union is currently revising the Detergents Regulation to explicitly address microbial-based cleaning products, recognising them as distinct from traditional chemical detergents and marking the shift in regulatory focus on eco-friendly and biobased cleaning solutions.

Emma continued: “While the changes to the Detergents Regulation aim to ensure consumer safety, industry stakeholders, including us, are actively advocating for a more flexible and scientifically sound regulation which fosters both consumer safety and market innovation.

“These products represent an exciting step forward in sustainable cleaning technology, offering key environmental benefits and extended cleaning effects for various applications. As we move forward, these products will play a critical role in reshaping the sector with safer, more sustainable and highly effective solutions and it’s important that professionals involved in the manufacture, testing and distribution of these solutions are confident and compliant.”

A recording of the ‘Confidence in Microbial Cleaning: Safety & Regulatory Compliance’ webinar is available to view on demand by visiting https://www.bigmarker.com/imcd/Confidence-in-Microbial-Cleaning-Safety-Regulatory-Compliance?bmid=d064da897644&bmid_type=member&bmid=d064da897644.

Genesis Biosciences celebrates growth as team expands

Genesis Biosciences continues to lead the way in sustainable cleaning as it strengthens its laboratory and research and development teams.

Genesis’ lab team, led by Laboratory Manager Dr Kate Ledwoch, has doubled in size, expanding its wealth of expertise in developing products to positively impact cleaning across multiple industries and the environment.

Genesis Biosciences has additionally grown its research and development team, curating a diverse, skilled team of scientists. The company’s focus on hiring highly qualified scientists and researchers marks a core differentiator from its competitors and allows them to conduct their innovative work in house, from research and development to the production of its performance-driven eco-benign® products and solutions.

Among the new appointments is Cardiff University Biological Science masters graduate Sophie Akers. Sophie specialises in bioinformatics, genomics and molecular ecology, and utilises her experience in these fields as a Research and Development Scientist at Genesis Biosciences.

Sophie said: “I am delighted to have joined Genesis Biosciences’ research and development team at such an exciting time for the company’s growth. Our work is incredibly important in not only supporting effective cleaning and wastewater treatment in several industries, but ensuring that this can be achieved in a sustainable way. It is great to be able to collaborate with the other experts in our lab and R&D teams and offer my own input into the development of our products.”

Dr Emma Saunders, General Manager at Genesis Biosciences, said: “Sophie is a tremendous addition to our R&D team, and offers a wealth of expertise in bioinformatics and genomics. We strive to recruit the top scientists and professionals to our team, and our strong growth is a testament to the hard work of our current and new team members.

“With our ever-growing team, we will continue to produce innovative and safe eco-benign® antimicrobial and microbial technologies that can be distributed globally.”

Genesis Biosciences reformulates Evogen concentrates

Genesis Biosciences has modernised the formulas of its Evogen concentrates, making the range 100% bio-based.

The company’s Evogen products combine innovative eco-benign® chemistry and application-specific beneficial bacteria to offer effective cleaning across a wide range of industries including facilities management and wastewater treatment.

The range’s performance-driven and environmentally-responsible microbial and antimicrobial technologies are designed to provide sustainable alternatives to the traditional harsh chemicals often used in cleaning products.

The reformulated products include the Evogen General Purpose Bio-cleaner Concentrate, Evogen Carpet and Upholstery Cleaner Concentrate, Evogen Exterior Hard Surface Cleaner Concentrate and the Evogen Odour Neutraliser Concentrate.

The project to revamp the Evogen formulas began in 2023, with testing and quality checks on compatibility, performance and stability concluding in Q1 of 2024.

The reformulated concentrates are now fully plant-derived by using co-formulants and fully biodegradable raw materials including bio-based alcohol ethoxylates and application-specific Bacillus consortia, thus ensuring compliance with current eco-accreditations such as ECOCERT’s European Ecolabel and recognised international standards for quality.

The improved concentrates can be diluted by formulators within the supply chain to produce 100% bio-based probiotic cleaning products for the end-user.

Dr Emma Saunders, General Manager at Genesis Biosciences, said: “We’ve always been proud to lead the way with products that are effective yet safe for the user and the environment, and our team is committed to continually improving our solutions such as our Evogen concentrates range.

“This is incredibly important as according to A.I.S.E (the International Association for Soaps, Detergents and Maintenance Products), just over half (53%) of pan-European consumers believe that cleaning products like detergents are safe for the people who use them and 28% believe they are safe for the environment. By providing alternatives to products derived from petrochemicals with harmful by-products, we can encourage consumers that there are safer options with low toxicity that deliver a superior cleaning performance.

“This is our greenest formula; our new Evogen concentrates use 100% bio-based ingredients which minimise the impact on the environment without compromising on the successful degradation of organic and malodorous compounds found on surfaces.”

Genesis Biosciences begins year with significant promotion

Genesis Biosciences has made a key promotion to drive innovation and ensure quality in its environmentally friendly microbial and antimicrobial product ranges.

Dr Kate Ledwoch has been promoted from Senior Scientist to Laboratory Manager.

Kate is an accomplished scientist whose work has previously been published in the British Journal of Hospital Medicine and the Journal of Hospital Infection. Her qualifications include a PhD in Applied Phycology from Cranfield University, an MSc in Biofuels Process Engineering and a BSc in Chemical Technology and Engineering.

Since joining Genesis Biosciences, Kate has excelled in spearheading important research and development (R&D) projects and has represented the company at numerous scientific conferences around Europe, raising industry awareness of Genesis’ innovative microbial technologies.

Stepping into her new role, Kate will play a pivotal part in driving R&D initiatives, optimising laboratory processes and ensuring the highest standards of quality and safety of their products.

On her promotion, Kate said: “I am delighted to be stepping into this new role and continuing to develop products with a purpose. Since joining Genesis Biosciences, I have seen firsthand how important our work is through its positive applications and, most importantly, how they are constantly being developed and improved.”

Dr Emma Saunders, General Manager at Genesis Biosciences, said: “We are very pleased to be promoting Kate to this position. She has shown exceptional leadership, strategic thinking, enthusiasm and is committed to fostering innovation, thus making her perfect for this role.

“I am confident that Kate’s vision and leadership will contribute significantly to our ongoing company success and commitment to scientific excellence.”